Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 495-98-7 | MDL No. : | MFCD24549958 |
Formula : | C12H20N2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UYYRKEKHAYEACU-UHFFFAOYSA-N |
M.W : | 208.30 | Pubchem ID : | 278143 |
Synonyms : |
|
Num. heavy atoms : | 15 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.67 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 63.63 |
TPSA : | 45.75 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.05 cm/s |
Log Po/w (iLOGP) : | 2.76 |
Log Po/w (XLOGP3) : | 2.14 |
Log Po/w (WLOGP) : | 2.17 |
Log Po/w (MLOGP) : | 1.59 |
Log Po/w (SILICOS-IT) : | 3.64 |
Consensus Log Po/w : | 2.46 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.51 |
Solubility : | 0.641 mg/ml ; 0.00308 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.73 |
Solubility : | 0.386 mg/ml ; 0.00185 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.02 |
Solubility : | 0.0198 mg/ml ; 0.0000953 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.85 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313 | UN#: | N/A |
Hazard Statements: | H315-H319 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 21641-71-4 ]
6-(sec-Butyl)-3-isobutylpyrazin-2(1H)-one
Similarity: 0.97
[ 23127-00-6 ]
6-Methyl-3-propylpyrazin-2(1H)-one
Similarity: 0.90
[ 137232-66-7 ]
3-Isobutyl-1,6-dimethylpyrazin-2(1H)-one
Similarity: 0.89
[ 34098-41-4 ]
1-(3-(5-Isobutyl-6-oxo-1,6-dihydropyrazin-2-yl)propyl)guanidine
Similarity: 0.88
[ 21641-71-4 ]
6-(sec-Butyl)-3-isobutylpyrazin-2(1H)-one
Similarity: 0.97
[ 23127-00-6 ]
6-Methyl-3-propylpyrazin-2(1H)-one
Similarity: 0.90
[ 137232-66-7 ]
3-Isobutyl-1,6-dimethylpyrazin-2(1H)-one
Similarity: 0.89
[ 34098-41-4 ]
1-(3-(5-Isobutyl-6-oxo-1,6-dihydropyrazin-2-yl)propyl)guanidine
Similarity: 0.88